Charles Apgar

Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia

Gil D. Rabinovici, Constantine Gatsonis, Charles Apgar et al. · JAMA · 2019 · 667 citations · Full text

Medicine, Geriatric Medicine, Neurology +17

Federated learning enables big data for rare cancer boundary detection

Sarthak Pati, Ujjwal Baid, Brandon Edwards et al. · Nature Communications · 2022 · 340 citations · Full text

Computing, Computer Science, Oncology +13

Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia

Consuelo H. Wilkins, Charles Windon, Peggye Dilworth‐Anderson et al. · JAMA Neurology · 2022 · 143 citations · Full text

Medicine, Geriatric Medicine, Neurology +17

Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive Impairment

Yan Hu, Kristopher M. Kirmess, Matthew R. Meyer et al. · JAMA Network Open · 2022 · 136 citations · Full text

Medicine, Neurology, Neuroscience +17

Clinical validation of the PrecivityAD2 blood test: A mass spectrometry‐based test with algorithm combining %p‐tau217 and Aβ42/40 ratio to identify presence of brain amyloid

Matthew R. Meyer, Kristopher M. Kirmess, Stephanie Eastwood et al. · Alzheimer s & Dementia · 2024 · 103 citations · Full text

Medicine, Pathology, Dementia +16